Aims The primary goal of the CANagliflozin cardioVascular Assessment Research\Renal (CANVAS\R) is to determine if the favourable ramifications of inhibition from the sodium glucose co\transporter 2 (SGLT2) on blood sugar, blood circulation pressure and bodyweight are accompanied by protection against adverse renal outcomes. of coronary disease, 22.3% had microalbuminuria and 8.7% had macroalbuminuria. The mean… Continue reading Aims The primary goal of the CANagliflozin cardioVascular Assessment Research\Renal (CANVAS\R)